CHICAGO — The diabetes/weight loss drug semaglutide is associated with a significantly greater risk for repeat operations in patients with diabetes who require lumbar surgery, a new study suggests. The risk for additional surgeries was even higher among patients taking the popular weight loss and diabetes drug for longer periods of time…
